We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

90 hedge funds and large institutions have $148M invested in Foghorn Therapeutics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

3% more funds holding

Funds holding: 87 → 90 (+3)

0.28% more ownership

Funds ownership: 72.41% → 72.69% (+0.28%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

13% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 30

22% less capital invested

Capital invested by funds: $190M → $148M (-$42.4M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $3K

Holders
90
Holders Change
+3
Holders Change %
+3.45%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
26
Reduced
30
Closed
5
Calls
–
Puts
$3K
Net Calls
-$3K
Net Calls Change
-$7K

Top Buyers

1
Raymond James Financial
Raymond James Financial
Florida
+$861K
2
DCM
DAFNA Capital Management
California
+$538K
3
SCM
SCS Capital Management
Massachusetts
+$488K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$387K
5
Squarepoint
Squarepoint
New York
+$201K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$460K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$390K
3
Millennium Management
Millennium Management
New York
-$328K
4
BBA
Baker Bros. Advisors
New York
-$213K
5
JP Morgan Chase
JP Morgan Chase
New York
-$184K
Name Holding Trade Value Shares
Change 		Change in
Stake
GFM
76
GF Fund Management
China
$5.2K +$1.17K +257 +22%
Russell Investments Group
77
Russell Investments Group
United Kingdom
$5K -$483 -106 -7%
SS
78
Sunbelt Securities
Texas
$3.65K – – –
Ohio Public Employees Retirement System (OPERS)
79
Ohio Public Employees Retirement System (OPERS)
Ohio
$3.17K +$3.96K +869 New
AB
80
Amalgamated Bank
New York
$2K – – –
PD
81
Point72 (DIFC)
United Arab Emirates
$1.37K -$606 -133 -26%
SCM
82
Sterling Capital Management
North Carolina
$686 -$757 -166 -47%
PNC Financial Services Group
83
PNC Financial Services Group
Pennsylvania
$515 +$497 +109 +341%
TFM
84
TFC Financial Management
Massachusetts
$449 – – –
SS
85
SBI Securities
Japan
$365 +$451 +99 +9,900%
GI
86
GAMMA Investing
California
$350 -$68 -15 -14%
EWA
87
EverSource Wealth Advisors
Alabama
$350 +$438 +96 New
TWD
88
True Wealth Design
Ohio
$296 +$369 +81 New
IA
89
IFP Advisors
Florida
$7 – – –
BBA
90
Baker Bros. Advisors
New York
– -$213K -45,027 Closed
CC
91
Corton Capital
Ontario, Canada
– -$163K -34,576 Closed
CSS
92
Cubist Systematic Strategies
Connecticut
– -$51.4K -10,895 Closed
Manulife (Manufacturers Life Insurance)
93
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$48.6K -10,295 Closed
Royal Bank of Canada
94
Royal Bank of Canada
Ontario, Canada
– -$11.6K -2,555 -99%
RS
95
R Squared
Hong Kong
– -$142 -30 Closed
1 2 3
4

FHTX Hedge Fund Activity: Q1 2025 in Review

90 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q1 2025, worth a combined $148M — down 22% from $190M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new FHTX positions and 5 closed out — a net gain of 3 holders — while 26 added to existing stakes and 30 trimmed.

The largest buyer was Raymond James Financial, adding an estimated $861K. The largest seller was Fidelity Investments, cutting an estimated $460K.

  • 90 institutional investors held Foghorn Therapeutics (FHTX) as of Q1 2025, up from 87 in Q4 2024.
  • Funds reported $148M of Foghorn Therapeutics stock for Q1 2025, down 22% quarter-over-quarter.
  • 8 funds opened new Foghorn Therapeutics positions in Q1 2025 and 5 closed out, a net change of +3 holders.
  • The largest Foghorn Therapeutics buyer in Q1 2025 was Raymond James Financial, an estimated $861K added.
  • The largest Foghorn Therapeutics seller in Q1 2025 was Fidelity Investments, an estimated $460K sold.

Based on aggregated 13F filings for Q1 2025.